Ikarian Capital, LLC Immuno Precise Antibodies Ltd. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.8 - $6.08 $61,624 - $98,599	-16,217 Reduced 20.88%	61,433 $237,000
Q1 2022 May 13, 2022	BUY	$3.64 - $6.49 $13,715 - $24,454	3,768 Added 5.1%	77,650 $399,000
Q3 2021 Nov 15, 2021	SELL	$5.14 - $13.22 $391,246 - $1.01 Million	-76,118 Reduced 50.75%	73,882 $459,000
Q1 2021 May 17, 2021	BUY	$8.84 - $17.0 $1.33 Million - $2.55 Million	150,000 New	150,000 $1.47 Million

1.9M

Ticker IPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,836,700
Market Cap $8.44M
Description
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.